Anumana
Cambridge
About Anumana
Anumana develops AI algorithms that analyze ECG data to support early diagnosis of cardiovascular conditions. The company focuses on enhancing cardiac care through innovative technology, providing tools that assist healthcare professionals in identifying potential heart issues. Anumana's platform extends beyond diagnostics, aiming to improve patient outcomes throughout the entire continuum of cardiovascular care, including perioperative and acute settings. By utilizing machine learning techniques, Anumana aims to refine screening processes, making it easier for clinicians to detect heart diseases and intervene promptly. This approach contributes to more efficient healthcare delivery and better management of cardiovascular health.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $117.7M
- Funding stage: Late Stage Venture
- Last round: Series C (Apr 2025)
- Website: anumana.ai
- Phone: 800-395-2715
Industries & Categories
Artificial Intelligence (AI), Health Care, Health Diagnostics, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/anumana-118128 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.